Alkermes plc (ALKS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$43.69
-6.47%
Mkt Cap $7.71B
Analyst Ratings
Buy
15
Hold
2
Sell
1
Price Target (28 analysts)
$52.60
Range $43.00 – $65.00
Implied Upside
+20.4%
Consensus $52.60 vs current $43.69